Ligand increases offer for Neurogen
22 December 2009
Simon Varcoe
Please Login to read the full article.
22 December 2009
Simon Varcoe
simon.varcoe@informa.com
Ligand Pharmaceuticals is to pay Neurogen an additional $600,000 in an amendment to the merger agreement that rescued the cash-stricken neurological and psychiatric drug developer.
Neurogen will receive the funds in addition to the 4.2 million shares that Ligand will issue and four series...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: PhRMA hopes Part D savings will be muscle against 'Super Congress' cuts
- US Capitol Capsule: Supreme Court takes another stab at refining US patent law
- US Capitol Capsule: Use of mind-altering medicines in children, elderly under fire
- US Capitol Capsule: And they're off: First Supreme Court health reform briefs filed
COMMENT
Other Informa Comment
FEATURES
- Interview: Adimab's Gerngross seeks two sweethearts
- Chinese producers may be losing price edge to India, says Granules MD
EVENTS
09 February 2012
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
